Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| basal cell | 5 studies | 27% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| esophagus | 3 studies | 46% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| tonsil | 0% | 0 | 0 / 0 | 96% | 24.50 | 43 / 45 |
| esophagus | 39% | 8518.88 | 569 / 1445 | 53% | 8.94 | 97 / 183 |
| skin | 72% | 5580.41 | 1294 / 1809 | 7% | 1.20 | 34 / 472 |
| uterus | 2% | 206.24 | 3 / 170 | 48% | 12.84 | 219 / 459 |
| kidney | 37% | 564.11 | 33 / 89 | 0% | 0.09 | 2 / 901 |
| lung | 0% | 0 | 0 / 578 | 32% | 6.57 | 368 / 1155 |
| bladder | 0% | 0 | 0 / 21 | 17% | 3.11 | 88 / 504 |
| thymus | 0% | 0.59 | 1 / 653 | 15% | 6.65 | 89 / 605 |
| prostate | 10% | 85.16 | 25 / 245 | 0% | 0.03 | 1 / 502 |
| breast | 7% | 50.48 | 32 / 459 | 3% | 0.37 | 34 / 1118 |
| pancreas | 0% | 1.10 | 1 / 328 | 4% | 0.52 | 7 / 178 |
| liver | 3% | 18.04 | 6 / 226 | 1% | 0.05 | 3 / 406 |
| intestine | 0% | 0.73 | 1 / 966 | 2% | 0.31 | 11 / 527 |
| stomach | 1% | 13.96 | 2 / 359 | 0% | 0.09 | 1 / 286 |
| adipose | 1% | 13.25 | 9 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 0% | 5.32 | 4 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 4.79 | 3 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.03 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| brain | 0% | 0 | 0 / 2642 | 0% | 0 | 0 / 705 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0060316 | Biological process | positive regulation of ryanodine-sensitive calcium-release channel activity |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CALML3 |
| Protein name | Calmodulin-like protein 3 (CaM-like protein) (CLP) (Calmodulin-related protein NB-1) |
| Synonyms | |
| Description | FUNCTION: May function as a specific light chain of unconventional myosin-10 (MYO10), also enhances MYO10 translation, possibly by acting as a chaperone for the emerging MYO10 heavy chain protein. May compete with calmodulin by binding, with different affinities, to cellular substrates. . |
| Accessions | ENST00000315238.3 P27482 |